Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

IQVIA Holdings, Inc. Common Stock (NY:IQV)

260.58 +1.70 (+0.66%)
Delayed Quote Updated: 11:11 AM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
News headline image
IQVIA (IQV) Shares Skyrocket, What You Need To Know
What Happened? Shares of clinical research company IQVIA (NYSE: IQV) jumped 12.9% in the morning session after the company reported second-quarter results th... 
Via StockStory
Topics Artificial Intelligence
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
IQVIA (NYSE:IQV): Quality Stock Surges on Q2 Earnings Beat and Raised Outlook ↗
Via Chartmill
Topics Earnings
News headline image
IQVIA’s (NYSE:IQV) Q2 CY2026 Sales Top Estimates, Stock Soars
Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 8.7% year on year to $4.37 billion. The compa... 
Via StockStory
News headline image
IQVIA Reports Second-Quarter 2026 Results
From IQVIA Holdings Inc.
Via Business Wire
News headline image
Earnings To Watch: IQVIA (IQV) Reports Q2 Results Tomorrow
Clinical research company IQVIA (NYSE: IQV) will be reporting earnings this Tuesday before market hours. Here’s what you need to know. IQVIA beat analysts’ r... 
Via StockStory
Topics Artificial Intelligence
Which S&P500 stocks are gapping on Thursday? ↗
Via Chartmill
News headline image
IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States
From IQVIA
Via Business Wire
News headline image
1 Cash-Producing Stock to Target This Week and 2 We Question
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
Topics Energy
News headline image
IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026
From IQVIA
Via Business Wire
News headline image
Why Is IQVIA (IQV) Stock Soaring Today
What Happened? Shares of clinical research company IQVIA (NYSE: IQV) jumped 5.8% in the afternoon session after Baird raised its price target on the stock to... 
Via StockStory
Topics Artificial Intelligence
Top S&P500 movers in Wednesday's session ↗
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stocks on Our Buy List and 2 We Turn Down
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
Topics Artificial Intelligence
Which S&P500 stocks are gapping on Wednesday? ↗
Via Chartmill
News headline image
IQVIA (IQV): Buy, Sell, or Hold Post Q1 Earnings?
Over the last six months, IQVIA’s shares have sunk to $177.52, producing a disappointing 19.8% loss - a stark contrast to the S&P 500’s 12.4% gain. This migh... 
Via StockStory
Topics Stocks
News headline image
Wiley and IQVIA Release Cross-Sector Report on AI’s Promise and Pressure Points Across Healthcare Value Chain
From John Wiley and Sons
Via Business Wire
News headline image
2 S&P 500 Stocks Worth Investigating and 1 Facing Headwinds
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch... 
Via StockStory
Topics Stocks
News headline image
Q1 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
Via StockStory
News headline image
IQVIA Announces Pricing of Senior Notes
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA Announces Offering of Senior Notes
From IQVIA Holdings Inc.
Via Business Wire
Discover which S&P500 stocks are making waves on Thursday. ↗
Via Chartmill
News headline image
IQVIA CEO to Speak at Jefferies Global Healthcare Conference
From IQVIA Holdings Inc.
Via Business Wire
Gapping S&P500 stocks in Wednesday's session ↗
Via Chartmill
News headline image
1 Mid-Cap Stock Worth Your Attention and 2 We Question
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco... 
Via StockStory
News headline image
IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities
From IQVIA
Via Business Wire
News headline image
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi... 
Via StockStory
Topics Economy
News headline image
IQVIA’s Q1 Earnings Call: Our Top 5 Analyst Questions
IQVIA’s first quarter results were positively received by the market, reflecting stronger-than-expected revenue growth and solid execution in both its Commer... 
Via StockStory
Topics Artificial Intelligence Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.